In oral squamous carcinoma NLRP3 activation promotes 5-Fluorouracil resistance “in vitro” and “in vivo” (56); and NLRP3 inflammasome has been detected in cisplatin-resistant lung cancer cell lines (57). This evidence concerns the gene NLRP3 and lung cancer.